Charlie Morris appointed to Almac’s clinical technologies executive team December 17, 2012 CenterWatch Staff
Eisai, UCL form drug discovery alliance for neurological diseases December 14, 2012 CenterWatch Staff
Lilly discontinues 1 of 3 phase III rheumatoid arthritis registration studies for tabalumab December 14, 2012 CenterWatch Staff
Bayer submits NDA for radium Ra 223 dichloride for castration-resistant prostate cancer December 14, 2012 CenterWatch Staff